OR9A3P

Across TCGA pan-cancer cohorts, OR9A3P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated OR9A3P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR9A3P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR9A3P expression acts as an unfavorable survival marker, although some lineages such as KIRC and THYM show a favorable association.

HNSC, OV, and CESC are the cancer types where OR9A3P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	IV	0.259	0.610	<.001	45	view →
OV	OS	Median	All	0.778	0.899	.002	36	view →
CESC	OS	Tertile	IV	0.289	0.650	.031	36	view →
STAD	DFS	Quartile	All	0.242	0.596	.001	35	view →
KIRP	OS	Tertile	II,III,IV	0.167	0.752	.007	35	view →
BLCA	DFS	Tertile	All	0.224	0.515	.017	27	view →
UVM	DFS	Tertile	All	0.305	0.775	.011	27	view →
THCA	DFS	Median	II,III,IV	0.854	0.954	.005	22	view →
MESO	OS	Median	All	0.289	0.635	.016	18	view →
ACC	OS	Quartile	All	0.628	0.868	.002	14	view →
KIRC	OS	Median	All	0.916	0.841	.002	7	view →
THYM	DFS	Median	III,IV	1.000	0.532	.023	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

OR9A3P–HNSC (DFS)

Open the HNSC breakdown →